Giá của Impel Pharmaceuticals Inc. là bao nhiêu (IMPL)

Giá của Impel Pharmaceuticals Inc. (IMPL) là $0.1011

Mũ thị trường của Impel Pharmaceuticals Inc. là gì (IMPL)

Giới hạn thị trường của Impel Pharmaceuticals Inc. (IMPL) là $1.96M

Doanh thu Impel Pharmaceuticals Inc. (IMPL)

Impel Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical firm, concentrating its efforts on creating and commercializing therapies for individuals in the United States who are affected by central nervous system (CNS) conditions. Leading its product portfolio is Trudhesa, an innovative upper nasal formulation of dihydroergotamine, specifically engineered for the prompt relief of acute migraine attacks. Furthermore, the company's development pipeline encompasses INP105, another upper nasal medication containing olanzapine, currently being advanced for the rapid treatment of agitation and aggressive behaviors associated with autism spectrum disorder. Impel is also progressing with INP107, an intranasal carbidopa/levodopa compound, which has already successfully concluded its Phase IIa clinical trial aimed at managing "OFF" episodes in Parkinson's disease patients. Initially established in 2008, the company was formerly known as Impel NeuroPharma, Inc. before rebranding to Impel Pharmaceuticals Inc. in April 2022. Its corporate headquarters are situated in Seattle, Washington.

Năm	Doanh thu	Thay đổi
Không đủ dữ liệu cho ngày được cung cấp.

Năm

Doanh thu

Thay đổi

Không đủ dữ liệu cho ngày được cung cấp.

Công ty	Doanh thu	Chênh lệch doanh thu	Quốc gia
Vertex Pharmaceuticals Incorporated VRTX.US	$12.62B	-	US
Argenx SE ARGX.US	$6.02B	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$10.11B	-	BE

Công ty

Doanh thu

Chênh lệch doanh thu

Quốc gia